DIFFUSIONSPLATTENASSAY FÜR ORITAVANCIN

Patent europeic · EP2737077 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2737077
Numer da la dumonda
EP12817566
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
26-07-2012
Publitgà
04-06-2014
Concedì
16-11-2016
La protecziun finescha il pli tard
25-07-2032
Proxima taxa annuala scadenta
31-07-2026
Classas IPC
C12Q 1/18 (2006.01)
C12Q 1/04 (2006.01)
G01N 33/94 (2006.01)
Prioritad
US 201161511608 P 26.07.2011
US 201261642099 P 03.05.2012
Dumonda PCT
PCT/US2012/048329 26.07.2012
Publicaziun PCT
WO2013/016529 31.01.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-08-2025

    Midada

    Published in Swissreg on 01.08.2025

  2. 01-08-2024

    Midada

    Published in Swissreg on 01.08.2024

  3. 01-08-2023

    Midada

    Published in Swissreg on 01.08.2023

  4. 01-08-2022

    Midada

    Published in Swissreg on 01.08.2022

  5. 16-11-2016

    Concedì

    Published in Swissreg on 16.11.2016

Partidas

Possessur

The Medicines Company

8 Sylvan Way, Parsippany, NJ 07054, US

Inventur

BELLEY, Adam

Beaconsfield Québec H9W 3X6, CA

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.